Literature DB >> 21793019

MicroRNA-199a/b-3p: a new star in the liver microcosmos.

Christoph Roderburg1, Christian Trautwein, Tom Luedde.   

Abstract

Entities:  

Year:  2011        PMID： 21793019     DOI： 10.1002/hep.24456

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.

Authors:  Fabian Benz; Christoph Roderburg; David Vargas Cardenas; Mihael Vucur; Jérémie Gautheron; Alexander Koch; Henning Zimmermann; Jörn Janssen; Lukas Nieuwenhuijsen; Mark Luedde; Norbert Frey; Frank Tacke; Christian Trautwein; Tom Luedde
Journal:  Exp Mol Med       Date:  2013-09-20       Impact factor: 8.718

2.  Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis.

Authors:  Lei Xin; Jun Gao; Dan Wang; Jin-Huan Lin; Zhuan Liao; Jun-Tao Ji; Ting-Ting Du; Fei Jiang; Liang-Hao Hu; Zhao-Shen Li
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

3.  Synergistic and independent action of endogenous microRNAs 122a and 199a for post-transcriptional liver detargeting of gene vectors.

Authors:  Bijay Dhungel; Charmaine A Ramlogan-Steel; Jason C Steel
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

4.  XSSJS inhibits hepatic fibrosis by promoting the miR-29b-3p/VEGFA axis in vitro and in vivo.

Authors:  Tianyao Zhang; Yu Yang; Baojia Wang; Long Wang; Dong Wang; Ning Cao; Jinyu Shi
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.